載入...

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade

Immune checkpoint inhibitors have demonstrated broad single-agent antitumor activity and a favorable safety profile that render them attractive agents to combine with other systemic anticancer therapies. Pancreatic cancer has been fairly resistant to monotherapy blockade of programmed cell death pro...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Transl Med
Main Authors: Gong, Jun, Hendifar, Andrew, Tuli, Richard, Chuang, Jeremy, Cho, May, Chung, Vincent, Li, Daneng, Salgia, Ravi
格式: Artigo
語言:Inglês
出版: Springer Berlin Heidelberg 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6174117/
https://ncbi.nlm.nih.gov/pubmed/30294755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0210-9
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!